Rheumatoid arthritis: New approaches for its evaluation and management
Identifieur interne : 001931 ( Istex/Checkpoint ); précédent : 001930; suivant : 001932Rheumatoid arthritis: New approaches for its evaluation and management
Auteurs : Elliott L. Semble [États-Unis]Source :
- Archives of Physical Medicine and Rehabilitation [ 0003-9993 ] ; 1995.
English descriptors
- Teeft :
- Active disease, Acute phase reactants, Adverse effects, American academy, American college, American congress, American rheumatism association, Arch intern, Arch phys, Arthritis, Arthritis care, Arthritis foundation, Arthritis rheum, Avocational activities, Bacterial arthritis, Better understanding, Blood counts, Bony erosions, Bull rheum, Clin, Clinical findings, Clinical improvement, Clinical practice, Clinical trials, Clinician, Cognitive dysfunction, Combination chemotherapy, Combination therapy, Complete blood count, Consensus study group, Conventional radiographs, Current status, Cyclosporin, Cytokine, Diabetes mellitus, Disability, Disease activity, Disease activity parameters, Disease duration, Distal interphalangeal joints, Dos, Drug therapy, Education programs, Electronic dolorimeter, European workshop, Extraarticular disease, February, Fish oils, Formal education, Fries, Functional capacity, Functional disability, Functional status, Gastric mucosal damage, Gold salts, Gouty arthritis, Grip strength, Health status, Heijde dmfm, Individual patients, Inflamed joints, Inflammation, Inflammatory arthritis, Injectable gold, Intern, Isotonic exercise, Joint damage, Joint disease, Joint inflammation, Joint motion, Joint scanning, Joint space, Joint tenderness, Kelley, Laboratory findings, Laboratory tests, Liver biopsy, Liver disease, Liver function tests, Magnetic resonance imaging, Martin vigorimeter, Methotrexate, Monoclonal, Monoclonal antibodies, Monoclonal antibody, Morning stiffness, Mucosal, Nonpharmacological treatments, Nonsteroidal drugs, Nsaid, Nutritional therapy, Oral gold, Osteoarthritis, Other cytokines, Other nsaids, Other therapies, Outcome studies, Patient education, Periarticular osteopenia, Phys, Physical disability, Physical examination, Physical medicine, Physical training, Pincus, Platelet count, Pool aerobics, Positive patients, Preliminary report, Previous studies, Progressive disease, Prospective study, Protein levels, Proximal interphalangeal joints, Psoriatic arthritis, Pulse steroids, Radiograph, Radiographic, Radiographic changes, Radiographic criterion, Radiographic damage, Recent studies, Receptor antagonists, Rehabil, Rehabilitation medicine, Rehabilitative techniques, Rheum, Rheumatic diseases, Rheumatoid, Rheumatoid arthritis, Rheumatoid arthritis patients, Rheumatoid factor, Rheumatoid hand, Rheumatol, Rheumatology, Rheumatology research, Riel plcm, Saunders, Secondline agents, Semble, Semin arthritis rheum, Septic arthritis, Serological studies, Serum creatinine, Several years, Severe loss, Severe morbidity, Side effects, Sledge, Small joints, Social workers, Standard methods, Steroid, Stiffness, Study period, Swollen joints, Synovial, Systemic lupus erythematosus, Tender joints, Therapeutic exercise, Therapeutic pyramid model, Thoracic duct drainage, Toxicity, Usual activities, Weight loss, Work disability, Work status.
Abstract
Abstract: Rheumatoid arthritis is a chronic, progressive disease with a long-term outcome characterized by significant morbidity, loss of functional capacity, and increased mortality. The cornerstone of therapy includes the appropriate melding of pharmacological, rehabilitative, and surgical treatments. New developments in the care of patients with rheumatoid arthritis have focused on aggressive pharmacological therapy early in the course of the illness, ongoing assessment of disease activity and patient function, and a better understanding of the role of rehabilitative techniques such as therapeutic exercise and behavioral approaches to education. This article synthesizes information from studies on recent advances in the management of rheumatoid arthritis outlining diagnosis and assessment, disability issues, outcome studies, current status of traditional and experimental pharmacological therapies, and new strategies of nonpharmacological treatments aimed at the clinician challenged by this fascinating disorder.
Url:
DOI: 10.1016/S0003-9993(95)80029-8
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
ISTEX:80F5CD4B02214C3D9CF1E9EF00A178A29DE513C0Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Rheumatoid arthritis: New approaches for its evaluation and management</title>
<author><name sortKey="Semble, Elliott L" sort="Semble, Elliott L" uniqKey="Semble E" first="Elliott L." last="Semble">Elliott L. Semble</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:80F5CD4B02214C3D9CF1E9EF00A178A29DE513C0</idno>
<date when="1995" year="1995">1995</date>
<idno type="doi">10.1016/S0003-9993(95)80029-8</idno>
<idno type="url">https://api.istex.fr/ark:/67375/6H6-BXMXJCM4-7/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">001686</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">001686</idno>
<idno type="wicri:Area/Istex/Curation">001686</idno>
<idno type="wicri:Area/Istex/Checkpoint">001931</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001931</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Rheumatoid arthritis: New approaches for its evaluation and management</title>
<author><name sortKey="Semble, Elliott L" sort="Semble, Elliott L" uniqKey="Semble E" first="Elliott L." last="Semble">Elliott L. Semble</name>
<affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Internal Medicine, Section on Rheumatology, Bowman Gray School of Medicine, Winston-Salem, NC</wicri:regionArea>
<placeName><region type="state">Caroline du Nord</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Archives of Physical Medicine and Rehabilitation</title>
<title level="j" type="abbrev">YAPMR</title>
<idno type="ISSN">0003-9993</idno>
<imprint><publisher>ELSEVIER</publisher>
<date type="published" when="1995">1995</date>
<biblScope unit="volume">76</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="190">190</biblScope>
<biblScope unit="page" to="201">201</biblScope>
</imprint>
<idno type="ISSN">0003-9993</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0003-9993</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="Teeft" xml:lang="en"><term>Active disease</term>
<term>Acute phase reactants</term>
<term>Adverse effects</term>
<term>American academy</term>
<term>American college</term>
<term>American congress</term>
<term>American rheumatism association</term>
<term>Arch intern</term>
<term>Arch phys</term>
<term>Arthritis</term>
<term>Arthritis care</term>
<term>Arthritis foundation</term>
<term>Arthritis rheum</term>
<term>Avocational activities</term>
<term>Bacterial arthritis</term>
<term>Better understanding</term>
<term>Blood counts</term>
<term>Bony erosions</term>
<term>Bull rheum</term>
<term>Clin</term>
<term>Clinical findings</term>
<term>Clinical improvement</term>
<term>Clinical practice</term>
<term>Clinical trials</term>
<term>Clinician</term>
<term>Cognitive dysfunction</term>
<term>Combination chemotherapy</term>
<term>Combination therapy</term>
<term>Complete blood count</term>
<term>Consensus study group</term>
<term>Conventional radiographs</term>
<term>Current status</term>
<term>Cyclosporin</term>
<term>Cytokine</term>
<term>Diabetes mellitus</term>
<term>Disability</term>
<term>Disease activity</term>
<term>Disease activity parameters</term>
<term>Disease duration</term>
<term>Distal interphalangeal joints</term>
<term>Dos</term>
<term>Drug therapy</term>
<term>Education programs</term>
<term>Electronic dolorimeter</term>
<term>European workshop</term>
<term>Extraarticular disease</term>
<term>February</term>
<term>Fish oils</term>
<term>Formal education</term>
<term>Fries</term>
<term>Functional capacity</term>
<term>Functional disability</term>
<term>Functional status</term>
<term>Gastric mucosal damage</term>
<term>Gold salts</term>
<term>Gouty arthritis</term>
<term>Grip strength</term>
<term>Health status</term>
<term>Heijde dmfm</term>
<term>Individual patients</term>
<term>Inflamed joints</term>
<term>Inflammation</term>
<term>Inflammatory arthritis</term>
<term>Injectable gold</term>
<term>Intern</term>
<term>Isotonic exercise</term>
<term>Joint damage</term>
<term>Joint disease</term>
<term>Joint inflammation</term>
<term>Joint motion</term>
<term>Joint scanning</term>
<term>Joint space</term>
<term>Joint tenderness</term>
<term>Kelley</term>
<term>Laboratory findings</term>
<term>Laboratory tests</term>
<term>Liver biopsy</term>
<term>Liver disease</term>
<term>Liver function tests</term>
<term>Magnetic resonance imaging</term>
<term>Martin vigorimeter</term>
<term>Methotrexate</term>
<term>Monoclonal</term>
<term>Monoclonal antibodies</term>
<term>Monoclonal antibody</term>
<term>Morning stiffness</term>
<term>Mucosal</term>
<term>Nonpharmacological treatments</term>
<term>Nonsteroidal drugs</term>
<term>Nsaid</term>
<term>Nutritional therapy</term>
<term>Oral gold</term>
<term>Osteoarthritis</term>
<term>Other cytokines</term>
<term>Other nsaids</term>
<term>Other therapies</term>
<term>Outcome studies</term>
<term>Patient education</term>
<term>Periarticular osteopenia</term>
<term>Phys</term>
<term>Physical disability</term>
<term>Physical examination</term>
<term>Physical medicine</term>
<term>Physical training</term>
<term>Pincus</term>
<term>Platelet count</term>
<term>Pool aerobics</term>
<term>Positive patients</term>
<term>Preliminary report</term>
<term>Previous studies</term>
<term>Progressive disease</term>
<term>Prospective study</term>
<term>Protein levels</term>
<term>Proximal interphalangeal joints</term>
<term>Psoriatic arthritis</term>
<term>Pulse steroids</term>
<term>Radiograph</term>
<term>Radiographic</term>
<term>Radiographic changes</term>
<term>Radiographic criterion</term>
<term>Radiographic damage</term>
<term>Recent studies</term>
<term>Receptor antagonists</term>
<term>Rehabil</term>
<term>Rehabilitation medicine</term>
<term>Rehabilitative techniques</term>
<term>Rheum</term>
<term>Rheumatic diseases</term>
<term>Rheumatoid</term>
<term>Rheumatoid arthritis</term>
<term>Rheumatoid arthritis patients</term>
<term>Rheumatoid factor</term>
<term>Rheumatoid hand</term>
<term>Rheumatol</term>
<term>Rheumatology</term>
<term>Rheumatology research</term>
<term>Riel plcm</term>
<term>Saunders</term>
<term>Secondline agents</term>
<term>Semble</term>
<term>Semin arthritis rheum</term>
<term>Septic arthritis</term>
<term>Serological studies</term>
<term>Serum creatinine</term>
<term>Several years</term>
<term>Severe loss</term>
<term>Severe morbidity</term>
<term>Side effects</term>
<term>Sledge</term>
<term>Small joints</term>
<term>Social workers</term>
<term>Standard methods</term>
<term>Steroid</term>
<term>Stiffness</term>
<term>Study period</term>
<term>Swollen joints</term>
<term>Synovial</term>
<term>Systemic lupus erythematosus</term>
<term>Tender joints</term>
<term>Therapeutic exercise</term>
<term>Therapeutic pyramid model</term>
<term>Thoracic duct drainage</term>
<term>Toxicity</term>
<term>Usual activities</term>
<term>Weight loss</term>
<term>Work disability</term>
<term>Work status</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Abstract: Rheumatoid arthritis is a chronic, progressive disease with a long-term outcome characterized by significant morbidity, loss of functional capacity, and increased mortality. The cornerstone of therapy includes the appropriate melding of pharmacological, rehabilitative, and surgical treatments. New developments in the care of patients with rheumatoid arthritis have focused on aggressive pharmacological therapy early in the course of the illness, ongoing assessment of disease activity and patient function, and a better understanding of the role of rehabilitative techniques such as therapeutic exercise and behavioral approaches to education. This article synthesizes information from studies on recent advances in the management of rheumatoid arthritis outlining diagnosis and assessment, disability issues, outcome studies, current status of traditional and experimental pharmacological therapies, and new strategies of nonpharmacological treatments aimed at the clinician challenged by this fascinating disorder.</div>
</front>
</TEI>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Caroline du Nord</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Semble, Elliott L" sort="Semble, Elliott L" uniqKey="Semble E" first="Elliott L." last="Semble">Elliott L. Semble</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Istex/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001931 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd -nk 001931 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Istex |étape= Checkpoint |type= RBID |clé= ISTEX:80F5CD4B02214C3D9CF1E9EF00A178A29DE513C0 |texte= Rheumatoid arthritis: New approaches for its evaluation and management }}
![]() | This area was generated with Dilib version V0.6.33. | ![]() |